Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Director departure
Asset disposition
Inv. presentation
Quarterly results
Credit agrmnt [a]
|
|
Xtant Medical Holdings, Inc. (XTNT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/28/2015 |
8-K
| Credit agreement amendment, Acquisition/merger/asset purchase announced|
Docs:
|
"Stock purchase agreement by and among Bacterin, X-spine, and the sellers named therein",
"Amended and Restated Credit Agreement by and among Bacterin International, as the Borrower, the Lenders party thereto, and ROS Acquisition Offshore LP, as the Administrative Agent",
"Termination of Royalty Agreement by and between Bacterin and ROS Acquisition Offshore LP",
"Securities Purchase Agreement by and among Bacterin, ROS Acquisition Offshore LP and OrbiMed Royal Opportunities II",
"Purchase Agreement by and between Bacterin and Leerink Partners LLC",
"Consent of McGladrey LLP, Independent Auditors to X-spine",
"Consent of Battelle Rippe Kingston LLP, Independent Auditors to X-spine",
"INVESTOR CONTACT:",
"About Bacterin International Holdings Bacterin International Holdings, Inc. develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to promote bone growth, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries. Important Cautions Regarding Forward-looking Statements",
"Investor Overview" |
|
|
|